Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001521536-12-000890
Filing Date
2012-09-06
Accepted
2012-09-06 16:32:54
Documents
7
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 q1100733_10qa-biozone.htm 10-Q/A 27664
  Complete submission text file 0001521536-12-000890.txt   3153582

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE FILE bzne-20120630.xml EX-101.INS 408690
3 XBRL SCHEMA FILE bzne-20120630.xsd EX-101.SCH 40556
4 XBRL CALCULATION FILE bzne-20120630_cal.xml EX-101.CAL 42798
5 XBRL DEFINITION FILE bzne-20120630_def.xml EX-101.DEF 159556
6 XBRL LABEL FILE bzne-20120630_lab.xml EX-101.LAB 228226
7 XBRL PRESENTATION FILE bzne-20120630_pre.xml EX-101.PRE 223641
Mailing Address 4400 BISCAYNE BLVD SUITE 850 MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD SUITE 850 MIAMI FL 33137 800-689-0930
BIOZONE PHARMACEUTICALS, INC. (Filer) CIK: 0001412486 (see all company filings)

EIN.: 205978559 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 333-146182 | Film No.: 121077236
SIC: 2834 Pharmaceutical Preparations